A Phase 1 stem cell clinical trial for Multiple Sclerosis (MS) will be conducted by the researchers at Tisch Multiple Sclerosis Research Center New York. MS is a chronic human autoimmune disease that leads to myelin damage and neurodegeneration and impacts...

When injured or invaded by disease, our bodies have the innate response to heal and defend. What if it was possible to harness the power of the body to heal and then accelerate it in a clinically relevant way? What if we could help the body to heal itself better? The...